Special Year-End Discounts from DelveInsight

Market Publishers is happy to inform its valued customers that its research partner, DelveInsight, has recently launched a special year-end discount offer.

Only until December 31, 2018, you have a great chance to become an owner of research reports elaborated by DelveInsight at nice discounts:

  • 20% OFF on Single User License;
  • 30% OFF on Site License;
  • 40% OFF on Corporate License.

For any further details, please, give a call to Alison, our Sales Manager. You can reach her at +44 20 8123 2220. You can also send her an e-mail.

Found 2368 publications
Tuberous Sclerosis Complex (TSC) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Tuberous Sclerosis Complex (TSC) Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

Oct, 2018 118 pages
Tuberous Sclerosis Complex (TSC) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... Forecast of Tuberous Sclerosis Complex (TSC) 7MM Coverage Total Prevalent Cases of TSC Prevalent Cases according to segmentation: De novo mutations and Familiar Cases KEY ASSESSMENTS Patient Segmentation Disease Risk & Burden Risk of disease by the segmentation Factors ...

Oct, 2018 69 pages
Transthyretin Amyloidosis (ATTR) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Transthyretin Amyloidosis Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

Oct, 2018 158 pages
Transthyretin Amyloidosis (ATTR) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... 10 Year Forecast of Transthyretin Amyloidosis epidemiology 7MM Coverage Total Prevalent Cases of ATTR Prevalent Cases according to segmentation: Type prevalence i.e., Hereditary & Non-hereditary ATTR Diagnosed cases of ATTR KEY ASSESSMENTS Patient Segmentation Disease Risk & Burden Risk of disease by the ...

Oct, 2018
Primary Hyperoxaluria (PH) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Primary Hyperoxaluria (PH) Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

Oct, 2018 117 pages
Primary Hyperoxaluria (PH) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... Forecast of Primary Hyperoxaluria (PH) 7MM Coverage Total Prevalent Cases of PH Prevalent Cases according to segmentation: Type specific diagnosed prevalent cases and Age-Specific diagnosed prevalent cases KEY ASSESSMENTS Patient Segmentation Disease Risk & Burden Risk of disease ...

Oct, 2018 73 pages
Niemann-Pick Disease Type C (NPC) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Niemann-Pick Disease Type C (NPC) Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

Oct, 2018 132 pages
Niemann-Pick Disease Type C (NPC) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... of the disease epidemiology by total prevalent patient population, diagnosed population, sub-types and clinical distribution in 7MM KEY STRENGTHS 10 Year Forecast of Niemann-Pick Disease Type C (NPC) epidemiology 7MM Coverage Total Prevalent Cases of Niemann-Pick Disease Type C (NPC) Prevalent Cases according ...

Oct, 2018 76 pages
Neuroendocrine Tumors (NETs) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Neuroendocrine Tumors Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

Oct, 2018 263 pages
Neuroendocrine Tumors (NETs) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... leaders. Neuroendocrine Tumors Epidemiology Segmentation The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, total incident cases, diagnosed prevalent cases, symptom based classification of NETs (asymptomatic ...

Oct, 2018 125 pages
Hepatocellular Carcinoma (HCC) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... Forecast of Hepatocellular Carcinoma epidemiology G8 Coverage Total Incident Cases of HCC Incident Cases according to segmentation: Patients by line of therapies (first line and second line of therapies) Diagnosed cases of HCC KEY ASSESSMENTS Patient Segmentation Disease Risk ...

Oct, 2018 92 pages
Hepatocellular Carcinoma - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast G8 Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Hepatocellular Carcinoma Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

Oct, 2018 201 pages
Eosinophilic esophagitis (EoE) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Eosinophilic esophagitis (EoE) Report Assessment Current Treatment Practices Unmet Needs Detailed Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY BENEFITS ...

Oct, 2018 117 pages
Eosinophilic esophagitis (EoE) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... patient population The report provides the segmentation of the disease epidemiology by type i.e., Sex-Specific, Age-Specific Prevalence and Prevalence by Clinical Manifestation) in 7MM KEY STRENGTHS 10 Year Forecast of Eosinophilic esophagitis (EoE ...

Oct, 2018 57 pages
Primary Biliary Cholangitis (PBC) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast 7MM Coverage Epidemiology Segmentation Sub-type Segmentation Key Cross Competition Highly Analyzed Market Drugs Uptake Primary Biliary Cholangitis Report Assessment Current Treatment Practices Unmet Needs Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY ...

Oct, 2018 120 pages
Infantile Neuroaxonal Dystrophy - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Forecast 7MM Coverage Epidemiology Segmentation Sub-type Segmentation Key Cross Competition Highly Analyzed Market Drugs Uptake Infantile Neuroaxonal Dystrophy Report Assessment Current Treatment Practices Unmet Needs Pipeline Product Profiles Market Attractiveness Market Drivers and Barriers KEY ...

Oct, 2018 120 pages
STAT Inhibitors- Pipeline Insights, 2018 US$ 1,250.00 US$ 1,000.00

... methyl of Reata Pharmaceuticals. Products covered by Phase Phase III, Phase II, Phase I IND Pre-clinical & Discovery Inactive (Dormant and Discontinued) Overview of pipeline development activities for STAT Inhibitors Pipeline analysis of therapeutic drugs include but ...

Oct, 2018 124 pages
Oncolytic Virus Cancer Therapy- Pipeline Insights, 2018 US$ 2,000.00 US$ 1,600.00

... -1401) of Takara Bio. Products covered by Phase Phase III, Phase II, Phase I IND Pre-clinical & Discovery Inactive Overview of pipeline development activities for Oncolytic Virus Cancer Therapy Pipeline analysis of therapeutic drugs include but are not ...

Oct, 2018 200 pages
NF-κB Inhibitors- Pipeline Insights, 2018 US$ 1,250.00 US$ 1,000.00

... mechanism of action, route of administration and molecule type. This report provides detailed analysis of 12+ active products with more than 10 companies ... Phase Phase III, Phase II, Phase I Pre-clinical Inactive (Dormant and Discontinued) Overview of pipeline development activities for NF-κB Inhibitors Pipeline ...

Oct, 2018 150 pages
Dendritic Cancer Cell Therapy- Pipeline Insights, 2018 US$ 1,500.00 US$ 1,200.00

... , and Rocapuldencel-T of Argos Therapeutics. Products covered by Phase Phase III, Phase II, Phase I IND Pre-clinical & Discovery Inactive (Dormant & Discontinued) Overview of pipeline development activities for Dendritic Cancer Cell Therapy Pipeline analysis of therapeutic drugs include but are ...

Oct, 2018 160 pages
Cinryze - Drug Insights, 2018 US$ 1,000.00 US$ 800.00

... the historical and forecasted sales of Cinryze till 2022. The report also throws light on Cinryze`s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also ...

Oct, 2018 34 pages
Wet AMD- Pipeline Insight, 2018 US$ 1,500.00 US$ 1,200.00

... 'Wet AMD- Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Wet AMD. A detailed picture of the pipeline ... Dormant and Discontinued) Overview of pipeline development activities for Wet AMD Pipeline analysis of therapeutic drugs include ...

Oct, 2018 106 pages
WAS - Competitive Landscape and Market Insight, 2018 US$ 4,750.00 US$ 3,800.00

... can be delivered to the clients within 24 hours 'Wiskott Aldrich syndrome - Competitive Landscape and Market Insight, 2018', report provides comprehensive Insight about ... Insight to formulate effective R&D development strategies Gaining a full picture of the Competitive Landscape for Evidence based Decisions

Oct, 2018 54 pages
Retinal Degeneration - Pipeline Insight, 2018 US$ 1,500.00 US$ 1,200.00

... Retinal Degeneration- Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Retinal Degeneration. A detailed picture of the pipeline ... ) Overview of pipeline development activities for Retinal Degeneration Pipeline analysis of therapeutic ...

Oct, 2018 217 pages
Pemphigus Vulgaris (PV) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Pemphigus Vulgaris (PV) Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake ...

Oct, 2018 152 pages
Pemphigus Vulgaris (PV) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... leaders. Pemphigus Vulgaris Epidemiology Segmentation The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalent cases by Severity (Mild, Moderate and Severe), diagnosed and ...

Oct, 2018 75 pages
PARP INHIBITORS - COMPETITIVE LANDSCAPE, PIPELINE AND MARKET ANALYSIS, 2018 US$ 3,000.00 US$ 2,400.00

... can be delivered to the clients within 48 hours 'PARP Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2018', report provides comprehensive ... to available databases. SCOPE The report provides competitive pipeline landscape of PARP Inhibitors The report provides the marketed drugs information ...

Oct, 2018 159 pages
Opioid Receptor Antagonists- Pipeline Insight, 2018 US$ 1,500.00 US$ 1,200.00

... within 48 hours 'Opioid Receptor Antagonists- Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Opioid Receptor Antagonists. A detailed picture of the pipeline landscape is provided ...

Oct, 2018 99 pages
Neuroblastoma (NB)- Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... Forecast of Neuroblastoma epidemiology 7MM Coverage Total Incident Cases of Neuroblastoma Incident Cases according to segmentation: Neuroblastoma cases by risk groups (low, intermediate and high risk group) in 7MM KEY ASSESSMENTS Patient Segmentation Disease Risk ...

Oct, 2018 60 pages
Natural Killer Cell Therapies - Competitive Landscape, Technology and Pipeline Analysis, 2018 US$ 2,950.00 US$ 2,360.00

... development partner and chemical information Coverage of the Natural Killer Cell Therapies pipeline on the basis of target, MOA, route ... scenario across Natural Killer Cell Therapies to formulate effective R&D strategies Assess challenges and opportunities that influence Natural Killer Cell Therapies R&D Gather ...

Oct, 2018 236 pages
Narcolepsy - Pipeline Insight, 2018 US$ 1,250.00 US$ 1,000.00

... Narcolepsy - Pipeline Insight, 2018' report by DelveInsight outlays comprehensive Insight of present scenario and growth prospects across Narcolepsy. A detailed picture of the pipeline ... and Discontinued) Overview of pipeline development activities for Narcolepsy Pipeline analysis of therapeutic drugs include ...

Oct, 2018 76 pages
Metachromatic Leukodystrophy - Competitive Landscape and Market Insights, 2018 US$ 5,500.00 US$ 4,400.00

... be delivered to the clients within 48 hours 'Metachromatic Leukodystrophy - Competitive Landscape and Market Insights, 2018', report provides comprehensive ... available databases. SCOPE The report provides competitive pipeline landscape of Metachromatic Leukodystrophy The report provides the insight of current ...

Oct, 2018 58 pages
Isocitrate Dehydrogenase (IDH) inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2018 US$ 3,000.00 US$ 2,400.00

... partner and chemical information Coverage of the Isocitrate Dehydrogenase (IDH) inhibitors pipeline on the basis of target, MOA ... across Isocitrate Dehydrogenase (IDH) inhibitors to formulate effective R&D strategies Assess challenges and opportunities that influence Isocitrate Dehydrogenase (IDH) inhibitors ...

Oct, 2018 59 pages
Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2018 US$ 7,500.00 US$ 6,000.00

... within 48 hours 'Epilepsy- Competitive Landscape, Market and Pipeline Analysis, 2018', report provides comprehensive insights about marketed and pipeline drugs ... databases. SCOPE The report provides competitive pipeline landscape of Epilepsy The report provides the marketed drugs information including its sales ...

Oct, 2018 147 pages
C-X-C Chemokine Receptor (CXCR) Inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2018 US$ 3,000.00 US$ 2,400.00

... partner and chemical information Coverage of the C-X-C Chemokine Receptor (CXCR) Inhibitors pipeline on the basis of target, MOA, ... C-X-C Chemokine Receptor (CXCR) Inhibitors to formulate effective R&D strategies Assess challenges and opportunities that influence C-X-C Chemokine Receptor (CXCR) Inhibitors R&D ...

Oct, 2018 139 pages
Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Pipeline and Market Analysis, 2018 US$ 2,950.00 US$ 2,360.00

... development partner and chemical information Coverage of the Chimeric Antigen Receptor (CAR) T cell Immunotherapy pipeline on the basis of ... Chimeric Antigen Receptor (CAR) T cell Immunotherapy to formulate effective R&D strategies Assess challenges and opportunities that influence Chimeric Antigen Receptor (CAR ...

Oct, 2018 289 pages
Bruton's Tyrosine Kinase (BTK) Inhibitors - Competitive Landscape, Pipeline and Market Analysis, 2018 US$ 3,000.00 US$ 2,400.00

... partner and chemical information Coverage of the Bruton's Tyrosine Kinase (BTK) Inhibitors pipeline on the basis of target, MOA ... scenario Bruton's Tyrosine Kinase (BTK) Inhibitors to formulate effective R&D strategies Assess challenges and opportunities that influence Bruton's Tyrosine Kinase (BTK) Inhibitors ...

Oct, 2018 152 pages
Amyotrophic Lateral Sclerosis - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2027 US$ 7,500.00 US$ 6,000.00

... can be delivered to the clients within 48 hours 'Amyotrophic Lateral Sclerosis - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2027 ... available databases. SCOPE The report provides competitive pipeline landscape of Amyotrophic Lateral Sclerosis The report provides the marketed drugs ...

Oct, 2018 300 pages
Allergic Conjunctivitis (AC) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Allergic Conjunctivitis Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake ...

Oct, 2018 118 pages
Allergic Conjunctivitis (AC) - Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... Forecast of Allergic Conjunctivitis epidemiology 7MM Coverage Total Prevalent Cases of AC Prevalent Cases according to segmentation: Subtype-specific prevalence i.e., Acute & Chronic AC Diagnosed cases of AC KEY ASSESSMENTS Patient Segmentation Disease Risk & Burden Risk of disease by the segmentation Factors ...

Oct, 2018 60 pages
Adrenoleukodystrophy (ALD) Market Insights, Epidemiology and Market Forecast - 2027 US$ 6,251.00 US$ 5,001.00

... Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Adrenoleukodystrophy Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake ...

Oct, 2018 136 pages
Adrenoleukodystrophy (ALD)- Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... to the patient population The report provides the segmentation of the disease epidemiology by Adrenoleukodystrophy by clinical manifestation and diagnosed prevalent cases of CALD by segmentation in 7MM KEY STRENGTHS 10 Year Forecast of Adrenoleukodystrophy epidemiology 7MM ...

Oct, 2018 65 pages
ADA-SCID - Competitive Landscape and Market Insight, 2018 US$ 4,750.00 US$ 3,800.00

... can be delivered to the clients within 24 hours 'ADA-SCID - Competitive Landscape and Market Insight, 2018', report provides comprehensive Insight about ... to available databases. SCOPE The report provides competitive pipeline landscape of ADA-SCID The report provides the marketed drugs information including ...

Oct, 2018 50 pages
Acute Renal Failure (ARF)- Epidemiology Forecast to 2027 US$ 3,250.00 US$ 2,600.00

... opinion leaders. Acute Renal Failure Epidemiology Segmentation The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [incidence population of ARF, Sex-Specific Incident Hospitalization cases and Stage-wise Incidence of Acute Renal Failure] scenario ...

Oct, 2018 60 pages
Acute Renal Failure (ARF) - Market Insights, Epidemiology and Market Forecast-2027 US$ 6,250.00 US$ 5,000.00

... Insights Patient Population Therapeutic Approaches Pipeline Analysis Market Size and Trends Market Opportunities Impact of upcoming Therapies Acute Renal Failure Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake ...

Oct, 2018 114 pages
Hereditary Angioedema - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018 US$ 2,000.00 US$ 1,600.00

... marketed and Phase III products for Hereditary Angioedema . The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. Global API Manufacturers of Marketed ...

Jan, 2018 60 pages
Severe Psoriasis - Epidemiology Forecast to 2025 US$ 2,950.00 US$ 2,360.00

... risk factors, disease burden with special emphasis on the unmet medical needs associated with the Severe Psoriasis. The report contains the targeted patient populations and the forecast ...

Nov, 2017 40 pages
Histone deacetylase (HDAC) Inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2017 US$ 3,250.00 US$ 2,600.00

... within 25 Hours DelveInsight’s, “Histone deacetylase (HDAC) Inhibitors - Competitive Landscape, Market, and Pipeline Analysis, 2017” report provides ... Licensing, Deals and Patent details (marketed and pipeline) related to HDAC inhibitors are also covered Insights on marketed products including detailed marketed ...

Nov, 2017
Diabetic Retinopathy - Competitive Landscape, Pipeline and Market Analysis, 2017 US$ 6,950.00 US$ 5,560.00

... DelveInsight’s Diabetic Retinopathy - Competitive Landscape, Pipeline and Market Analysis, 2017 report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven ... the historical and forecasted epidemiology data for Diabetic Retinopathy prevalent or incident cases segmented by age, sex ...

Nov, 2017 100 pages
Vitiligo - Epidemiology Forecast to 2025 US$ 2,950.00 US$ 2,360.00

... 10 years epidemiology historical and forecasted data of Insulin Resistance. The Report also discusses the prevailing risk factors, disease burden with ... shaping and driving the global Vitiligo market. Identifying prevalent patient populations as well as risk factors in the global Vitiligo market will help to ...

Nov, 2017 40 pages
1 2 3 4 5 next
Skip to top